Search Antibody, Protein, and ELISA Kit Solutions

TNFRSF11A Antibody (OAPB00460)

0.1 mg
$375.00
In Stock
Request Bulk Order Quote

Conjugation Options

OAPB00460-FITC Conjugated

OAPB00460-HRP Conjugated

OAPB00460-Biotin Conjugated

Gene Symbol:
TNFRSF11A
Official Gene Full Name:
Tumor necrosis factor receptor superfamily member 11A
NCBI Gene Id:
8792
Protein Name:
Tumor necrosis factor receptor superfamily member 11A
Swissprot Id:
Q9Y6Q6
Replacement Item:
This antibody may replace item sc-34248 from Santa Cruz Biotechnology.
Description of Target:
a member of the TNF-ligand family
Host:
Rabbit
Clonality:
Polyclonal
Purification:
Affinity chromatography purified via peptide column
Application:
ELISA, WB, IHC
Tissue Tool:
Find tissues and cell lines supported by DNA array analysis to express TNFRSF11A.
RNA Seq:
Find tissues and cell lines supported by RNA-seq analysis to express TNFRSF11A.
Immunogen:
The immunogen for anti-sRANK Ligand antibody: antibody was raised against a 14 amino acid peptide from near the center of human sRANK-L.
Predicted Species Reactivity:
Human, Mouse, Rat
Predicted Homology Based on Immunogen Sequence:
Human; Mouse; Rat
Reconstitution and Storage:
sRANK Ligand antibody can be stored at 4C, stable for one year. As with all antibodies care should be taken to avoid repeated freeze thaw cycles. Antibodies should not be exposed to prolonged high temperatures.
Blocking Peptide:
For anti-TNFRSF11A (OAPB00460) antibody is Catalog # OEPB02570
Datasheets/Manuals:
Printable datasheet for anti-TNFRSF11A (OAPB00460) antibody
Application Info:
sRANK-L antibody can be used for detection of sRANK-L by Western blot at 0.25 - 0.5 ug/ml. (Optimal dilution should be determined by user)
:::
Buffer: Antibody is supplied in PBS containing 0.02% sodium azide.
Target Reference:
Wong BR, Rho J, Arron J, et al. TRANCE is a novel ligand of the tumor necrosis factor receptor family that activates c-Jun N-terminal kinase in T cells. J. Biol. Chem.1997; 272:25190-4.;Kong YY, Yoshida H, Sarosi I, et al. OPGL is a key regulator of osteoclastogenesis, lymphocyte development and lymph-node organogenesis. Nature 1999; 397:315-23.;Weitzmann MN, Cenci S, Rifas L, et al. Interleukin-7 stimulates osteoclast formation by up-regulating the T-cell production of soluble osteoclastogenic cytokines. Blood 2000; 96:1873-8.;Bharti AC, Takada Y, Shishodia S, et al. Evidence that receptor activator of the nuclear factor (NF)-kappaB ligand can suppress cell proliferation and induce apoptosis through activation of a NF-kappaB-independent and TRAF6-dependent mechanism. J. Biol. Chem.2004; 279:6065-76.

Product Reviews

Protocol:
Tips Information:

Tell us what you think about this item!

Write A Review
    Please, wait...